epileptic
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1.
Targeted resequencing in <span class="disease" id="23708187-0-25-34">epileptic</span> encephalopathies identifies de novo mutations in CHD2 and <span class="gene" id="23708187-0-93-100">SYNGAP1</span>.